Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)

NCT07136467 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07136467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
September 2, 2025
Completion date
August 31, 2027
Enrollment
2,795 (estimated)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, hidradenitis suppurativa, non-segmental vitiligo (nsv)